Simultaneous quantification of hepatic MRI-PDFF and R2*in a rabbit model with nonalcoholic fatty liver disease

被引:2
作者
Wang, Xiaomin [1 ,2 ]
Zhang, Xiaojing [1 ]
Ma, Lin [1 ]
Li, Shengli [3 ]
机构
[1] Chinese Peoples Liberat Army Gen Hosp, Dept Radiol, Beijing 100853, Peoples R China
[2] Tianjin Med Univ, Sch Med Imaging, Tianjin 300203, Peoples R China
[3] Capital Med Univ, Lab Anim Ctr, Beijing 100069, Peoples R China
关键词
nonalcoholic fatty liver disease; quantification; magnetic resonance imaging; proton density fat fraction; R2*; STEATOSIS; IRON; FRACTION; BIOPSY; DIAGNOSIS; LESIONS; DONORS; MICE; CT;
D O I
10.1007/s11427-017-9279-1
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Quantification of hepatic fat and iron content is important for early detection and monitoring of nonalcoholic fatty liver disease (NAFLD) patients. This study evaluated quantification efficiency of hepatic proton density fat fraction (PDFF) by MRI using NAFLD rabbits. R2* was also measured to investigate whether it correlates with fat levels in NAFLD. NAFLD rabbit model was successfully established by high fat and cholesterol diet. Rabbits underwent MRI examination for fat and iron analyses, compared with liver histological findings. MR examinations were performed on a 3.0T MR system using multi-echo 3D gradient recalled echo (GRE) sequence. MRI-PDFF showed significant differences between different steatosis grades with medians of 3.72% (normal), 5.43% (mild), 9.11% (moderate) and 11.17% (severe), whereas this was not observed in R2*. Close correlation between MRI-PDFF and histological steatosis was observed (r=0.78, P=0.000). Hepatic iron deposit was not found in any rabbits. There was no correlation between R2* and either liver MRI-PDFF or histological steatosis. MR measuring MRI-PDFF and R2* simultaneously provides promising quantification of steatosis and iron. Rabbit NAFLD model confirmed accuracy of MRI-PDFF for liver fat quantification. R2* measurement and relationship between fat and iron of NAFLD liver need further experimental investigation.
引用
收藏
页码:1107 / 1114
页数:8
相关论文
共 50 条
  • [41] A nonalcoholic fatty liver disease cirrhosis model in gerbil: the dynamic relationship between hepatic lipid metabolism and cirrhosis
    Li, Wei
    Guan, Zheng
    Brisset, Jean C.
    Shi, Qiaojuan
    Lou, Qi
    Ma, Yue
    Suriguga, Su
    Ying, Huazhong
    Sa, Xiaoying
    Chen, Zhenwen
    Quax, Wim J.
    Chu, Xiaofeng
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2018, 11 (01): : 146 - +
  • [42] Radial Ultrashort TE Imaging Removes the Need for Breath-Holding in Hepatic Iron Overload Quantification by R2*MRI
    Tipirneni-Sajja, Aaryani
    Krafft, Axel J.
    McCarville, M. Beth
    Loeffler, Ralf B.
    Song, Ruitian
    Hankins, Jane S.
    Hillenbrand, Claudia M.
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2017, 209 (01) : 187 - 194
  • [43] Type 2 diabetes mellitus increases the risk of hepatic fibrosis in individuals with obesity and nonalcoholic fatty liver disease
    Barb, Diana
    Repetto, Enrico M.
    Stokes, Michael E.
    Shankar, Sudha S.
    Cusi, Kenneth
    OBESITY, 2021, 29 (11) : 1950 - 1960
  • [44] Diagnostic value of MRI-derived liver surface nodularity score for the non-invasive quantification of hepatic fibrosis in non-alcoholic fatty liver disease
    Catania, Roberta
    Furlan, Alessandro
    Smith, Andrew D.
    Behari, Jaideep
    Tublin, Mitchell E.
    Borhani, Amir A.
    EUROPEAN RADIOLOGY, 2021, 31 (01) : 256 - 263
  • [45] A retinoic acid receptor β2 agonist reduces hepatic stellate cell activation in nonalcoholic fatty liver disease
    Trasino, Steven E.
    Tang, Xiao-Han
    Jessurun, Jose
    Gudas, Lorraine J.
    JOURNAL OF MOLECULAR MEDICINE-JMM, 2016, 94 (10): : 1143 - 1151
  • [46] A retinoic acid receptor β2 agonist reduces hepatic stellate cell activation in nonalcoholic fatty liver disease
    Steven E. Trasino
    Xiao-Han Tang
    Jose Jessurun
    Lorraine J. Gudas
    Journal of Molecular Medicine, 2016, 94 : 1143 - 1151
  • [47] Diagnostic value of MRI-derived liver surface nodularity score for the non-invasive quantification of hepatic fibrosis in non-alcoholic fatty liver disease
    Roberta Catania
    Alessandro Furlan
    Andrew D. Smith
    Jaideep Behari
    Mitchell E. Tublin
    Amir A. Borhani
    European Radiology, 2021, 31 : 256 - 263
  • [48] Increased Diacylglycerols Characterize Hepatic Lipid Changes in Progression of Human Nonalcoholic Fatty Liver Disease; Comparison to a Murine Model
    Gorden, D. Lee
    Ivanova, Pavlina T.
    Myers, David S.
    McIntyre, J. Oliver
    VanSaun, Michael N.
    Wright, J. Kelly
    Matrisian, Lynn M.
    Brown, H. Alex
    PLOS ONE, 2011, 6 (08):
  • [49] Cornus officinalis vinegar reduces body weight and attenuates hepatic steatosis in mouse model of nonalcoholic fatty liver disease
    Cao, Li
    Wu, Ying
    Li, Wenwen
    Zhang, Zengmiao
    Niu, Yaping
    Li, Chenchen
    Gu, Shaobin
    JOURNAL OF FOOD SCIENCE, 2022, 87 (07) : 3248 - 3259
  • [50] [18F]-BMS-747158-02PET imaging for evaluating hepatic mitochondrial complex 1dysfunction in a mouse model of nonalcoholic fatty liver disease
    Rokugawa, Takemi
    Momosaki, Sotaro
    Ito, Miwa
    Iimori, Hitoshi
    Kato, Yuki
    Abe, Kohji
    EJNMMI RESEARCH, 2017, 7